Palavras-chave
Como Citar
Resumo
Inflammation plays a central role in the pathogenesis of cardiovascular diseases (CVDs), with the pro-inflammatory cytokines IL-6 and IL-1β exerting direct influence on atherosclerosis progression, endothelial dysfunction, and adverse cardiovascular outcomes. This article reviews the correlations between ferritin, an inflammatory and metabolic biomarker, and the cytokines IL-6 and IL-1β, emphasizing their relevance in chronic inflammatory states and their association with cardiovascular dysfunction. Ferritin, often elevated in response to IL-6 and IL-1β activity, reflects both an attempt by the organism to mitigate oxidative damage and a marker of inflammatory aggravation. Recent studies, including clinical trials with anti-inflammatory agents such as canakinumab, colchicine, and tocilizumab, suggest that targeted inhibition of these inflammatory pathways can significantly improve cardiovascular outcomes. Finally, this review highlights the need for personalized therapeutic strategies, considering patients’ inflammatory profiles and biomarkers, to optimize clinical interventions and improve prognosis in CVDs.
Referências
CARRILLO, E.; et al. Ferritin’s structural and regulatory role in cellular processes. Journal of Cellular Physiology, 2015. Available at: https://onlinelibrary.wiley.com. Accessed on: 20 nov. 2024.
DEPALMA, Ralph G.; HAYES, Virginia W.; O’LEARY, Timothy J. Optimal serum ferritin level range: Iron status measure and inflammatory biomarker. Metallomics, v. 13, n. 6, p. mfab030, 2021.
DJAHANPOUR, Niousha et al. A systematic review of interleukins as diagnostic and prognostic biomarkers for peripheral artery disease. Biomolecules, v. 13, n. 11, p. 1640, 2023.
FONSECA, Óscar et al. New Perspectives on Circulating Ferritin: Its Role in Health and Disease. Molecules, v. 28, n. 23, p. 7707, 2023.
GERÔNIMO, Glaucio Mauren da Silva et al. Cardiovascular risk and its association with inflammatory biomarkers in dialysis chronic kidney disease. 2023.
GOLDSBOROUGH, Earl; OSUJI, Ngozi; BLAHA, Michael J. Assessment of cardiovascular disease risk: a 2022 update. Endocrinology and Metabolism Clinics, v. 51, n. 3, p. 483-509, 2022.
GONZÁLEZ, P. H.; et al. Biomarkers of inflammation and their cardiovascular implications. Archives of Cardiovascular Diseases, 2010. Available at: https://www.archives-cardiovascular.com. Accessed on: 20 nov. 2024.
GOTSMAN, Israel et al. Impaired fasting glucose: a predictor of reduced survival in patients with heart failure. European Journal of Heart Failure, v. 16, n. 11, p. 1190-1198, 2014.
GRAY, E.; et al. Iron metabolism and the vascular response in cardiovascular disease. Cardiovascular Research, 2001. Available at: https://academic.oup.com. Accessed on: 17 nov. 2024.
GREMMELS, Hendrik et al. A pro-inflammatory biomarker-profile predicts amputation-free survival in patients with severe limb ischemia. Scientific reports, v. 9, n. 1, p. 10740, 2019.
GUO, Songlin et al. Six-month results of stenting of the femoropopliteal artery and predictive value of interleukin-6: Comparison with high-sensitivity C-reactive protein. Vascular, v. 28, n. 6, p. 715-721, 2020.
JUSTI, Amanda; TATSCH, Pamela; SIQUEIRA, Luciano Oliveira. Ferritin: biomarker of cardiovascular diseases in diabetic patients. ABCS Health Sciences, v. 44, n. 1, 2019.
KATKENOV, Nurlubek et al. Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases. Journal of Cardiovascular Development and Disease, v. 11, n. 7, p. 206, 2024.
KOWDLEY, K. V.; et al. Ferritin and hepcidin in iron regulation: Implications for health and disease. Nature Reviews Gastroenterology & Hepatology, 2020. Available at: https://www.nature.com. Accessed on: 17 nov. 2024.
LI, W.; et al. Cytokines and ferritin: The immune-inflammatory axis in disease. Immunology Reviews, 2006. Available at: https://www.immunology.com. Accessed on: 20 nov. 2024.
LIBRA, M. et al. Analysis of G (-174) C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. Journal of clinical pathology, v. 59, n. 2, p. 211-215, 2006.
MAHROUN, M.; et al. Ferritin: Beyond iron storage, its role in immunity and inflammation. Clinical Immunology, 2022. Available at: https://www.sciencedirect.com. Accessed on: 17 nov. 2024.
MARTÍNEZ, Gonzalo J. et al. Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. Journal of the American Heart Association, v. 4, n. 8, p. e002128, 2015.
PARRY-JONES, Adrian R. et al. Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH). European Stroke Journal, v. 8, n. 3, p. 819-827, 2023.
RAMALLAL, Raul et al. Dietary inflammatory index and incidence of cardiovascular disease in the SUN cohort. PloS one, v. 10, n. 9, p. e0135221, 2015.
RIDKER, Paul M. et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation, v. 118, n. 22, p. 2243-2251, 2008.
SIGNORELLI, Salvatore Santo et al. Plasma levels of inflammatory biomarkers in peripheral arterial disease: results of a cohort study. Angiology, v. 67, n. 9, p. 870-874, 2016.
SLAATS, J.; et al. Inflammatory pathways and ferritin: The bridge between iron metabolism and immunity. Current Opinion in Hematology, 2016. Available at: https://journals.lww.com. Accessed on: 20 nov. 2024.
SOYSAL, Pinar et al. Inflammation, frailty and cardiovascular disease. Frailty and cardiovascular diseases: Research into an elderly population, p. 55-64, 2020.
TAKAMURA, Taka-aki et al. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD). Atherosclerosis, v. 263, p. 192-197, 2017.
TARDIF, Jean-Claude et al. Efficacy and safety of low-dose colchicine after myocardial infarction. New England journal of medicine, v. 381, n. 26, p. 2497-2505, 2019.
URQUIZO, R.; et al. Elevated ferritin in inflammatory and infectious conditions: A critical analysis. Journal of Inflammation Research, 2019. Available at: https://www.dovepress.com. Accessed on: 20 nov. 2024.
VOLP, Ana Carolina Pinheiro et al. Inflammation biomarkers capacity in predicting the metabolic syndrome. Brazilian Archives of Endocrinology & Metabology, v. 52, p. 537-549, 2008.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Marcelo Flavio Gomes Jardim Filho